News
September 13, 2016

Imperiale named IU’s first Lawrence Lumeng Professor in Gastroenterology and Hepatology

Imperiale named IU’s first Lawrence Lumeng Professor in Gastroenterology and Hepatology

Imperiale named IU’s first Lawrence Lumeng Professor in Gastroenterology and Hepatology

INDIANAPOLIS — Regenstrief Institute investigator Thomas F. Imperiale, M.D., has been named the inaugural Lawrence Lumeng Professor in Gastroenterology and Hepatology at Indiana University School of Medicine. Dr. Imperiale is an internationally respected health services researcher and a clinical gastroenterologist.

Dr. Imperiale’s research, which has been funded by the National Cancer Institute, the National Institute of Diabetes and Digestive and Kidney Diseases, the Department of Veterans Affairs and other organizations, focuses on developing and testing screening strategies for colorectal cancer based on risk factors. His findings have been published in highly regarded journals including the New England Journal of Medicine, Journal of the American Medical Association, Annals of Internal Medicine and Gastroenterology.

In addition to the IU School of Medicine, Dr. Imperiale holds appointments with the Regenstrief Institute’s William M. Tierney Center for Health Services Research, the IU Center for Health Services and Outcomes Research, the VA Center for Health Information and the Indiana University Melvin and Bren Simon Cancer Center.

The new endowed professorship is named for Lawrence Lumeng, M.D., who was the Division Director ofDr. Thomas ImperialeGastroenterology and Hepatology in the Department of Medicine at the IU School of Medicine from 1983 to 2007. Under Dr. Lumeng’s leadership, the division pursued excellence in patient care and innovation in research and education.

“Dr. Lumeng hired me twenty years ago and I joke that he knew what I was going to do — outcomes research — before I knew it,” said Dr. Imperiale. “Screening for colorectal cancer saves lives. I am working to apply knowledge and technology to tailor colorectal cancer screening to an individual’s specific risk factors so that we can offer choices that are appropriate to that risk making screening more personalized, efficient, and in many cases, permissive and flexible.”

Dr. Imperiale is a graduate of City University of New York, earned his medical degree at New York University, was a resident in internal medicine at Case Western Reserve University and completed fellowships in clinical epidemiology at Yale University and in gastroenterology at Case Western Reserve University. Since joining IU in 1996 and the Regenstrief Institute in 2000 he has mentored more than thirty medical residents, fellows and junior faculty members. He is a recipient of the Regenstrief Institute’s Outstanding Investigator Award and the IU Trustee Teaching Award.

Related News

Dawn Bravata, MD

COVID did not affect stroke patient care quality or outcomes in nation’s largest healthcare system

In one of the first studies to investigate the overall quality of care and outcomes of stroke care for

Richard Holden and Noll Campbell

Helping the Helpers: Leveraging information technology to support caregiver medication management for the millions of individuals who live with dementia

Innovative methodology involves caregivers as co-designers not simply informants and includes virtual component More than 21 million people provide

Thankham Thyvalikakath

Linking medical and dental records in health information exchanges could improve dental patient safety, preventive care, and treatment outcomes

New $2.4 million NIH award supports efforts to go beyond current inefficient, paper-based approach to data sharing Dental professionals

karen crow

Experienced financial executive named Regenstrief Institute CFO

INDIANAPOLIS – Karen Crow, a veteran financial executive and consultant with more than 30 years of experience, will join